로딩 중…
지수 로딩 중…
Anika Therapeutics, Inc.
ANIK· NASDAQ· Health Care· Health Care Equipment & Services
$20.73+7.55%
2026-08-03
Financials
Valuation Metrics
Anika Therapeutics, Inc.'s Market Cap is $276M. At end of 2025 it was $137M. Ranked #2982 of 3,111 in US market (top 96%), #1346 of 1,445 on NASDAQ (top 93%), #189 of 206 in Health Care Equipment & Services (top 92%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $276M | US#2,982/3,111 Sec#189/206 |
| Revenue | $121M | US#2,764/3,111 Sec#184/206 |
| Net Income | $-4M | US—/3,111 Sec—/206 |
| Total Assets | $183M | US#3,003/3,111 Sec#192/206 |
| Net Assets | $137M | US#2,836/3,111 Sec#181/206 |
| Value | ||
| P/B | 2.01x | US#1,125/3,111 Sec#64/206 |
| P/S | 2.29x | US#1,343/3,111 Sec#94/206 |
| EV/EBITDA | 95.99x | US#2,424/3,111 Sec#131/206 |
| FCF Yield | 0.20% | US#2,228/3,111 Sec#143/206 |
| Profitability | ||
| ROE | -2.76% | US#2,256/3,111 Sec#119/206 |
| ROA | -2.06% | US#2,384/3,111 Sec#125/206 |
| Op. Margin | -4.24% | US#2,552/3,111 Sec#146/206 |
| Revenue Growth | 15.56% | US#945/3,111 Sec#62/206 |
| Financial Health | ||
| Debt Ratio | 33.65% | US#373/3,111 Sec#42/206 |
| Total Debt | $23M | US#2,704/3,111 Sec#172/206 |
| FCF | $562000.00 | US#2,261/3,111 Sec#146/206 |
| Cash | $38M | US#2,692/3,111 Sec#176/206 |
| Current Ratio | 4.48x | US#538/3,111 Sec#51/206 |
| Net Debt/EBITDA | -5.56x | US#60/3,111 Sec#5/206 |
| Performance | ||
| 1Y Return | 139.99% | US#181/3,111 Sec#17/206 |
| 1M Return | 34.99% | US#53/3,111 Sec#11/206 |
| From 52W High | -1.78% | US#6/3,111 Sec#1/206 |
| 1Y MDD | -34.65% | US#2,207/3,111 Sec#130/206 |
| Trading | ||
| Volume | 174,953 shares | US#2,711/3,111 Sec#189/206 |
| Trading Value | $4M | US#2,784/3,111 Sec#180/206 |
| Per Share | ||
| EPS | $-0.76 | US—/3,111 Sec—/206 |
| BPS | $10.05 | US#1,785/3,111 Sec#105/206 |